A Long-term Trial to Compare the Effects of Liraglutide and Sulphonylurea (Glimepiride) Both in Combination With Metformin on Clinical, Endothelial and Image Markers of Cardiovascular Risk in Patients With Type 2 Diabetes

NCT01593137 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Lack of patients with the criteria established in the protocol.

Conditions

Type 2 Diabetes

Interventions

DRUG: Liraglutide + metformin
DRUG: Glimepiride + metformin

Sponsor

Fundación Fernández-Cruz